Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
在法国早期准入计划中,阿特珠单抗和紫杉醇作为一线疗法用于晚期三阴性乳腺癌患者。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-40569-9
de Moura, Alexandre; Vuagnat, Perrine; Renouf, Benjamin; Pierga, Jean-Yves; Loirat, Delphine; Vaflard, Pauline; Lafayolle de la Bruyère, Charline; Chaumard-Billotey, Natacha; Hajjaji, Nawale; Ladoire, Sylvain; Dabakuyo, Sandrine; Patsouris, Anne; Frenel, Jean Sébastien; Nicolai, Vincent; Alexandre, Marie; Dohollou, Nadine; Grenier, Julien; Bourien, Heloïse; Bidard, François-Clément